GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Other Long Term Assets

ACME Laboratories (DHA:ACMELAB) Other Long Term Assets : BDT31 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Other Long Term Assets?

ACME Laboratories's other long-term assets for the quarter that ended in Mar. 2024 was BDT31 Mil.

ACME Laboratories's quarterly other long-term assets increased from Jun. 2023 (BDT32 Mil) to Sep. 2023 (BDT32 Mil) but then stayed the same from Sep. 2023 (BDT32 Mil) to Mar. 2024 (BDT31 Mil).

ACME Laboratories's annual other long-term assets declined from Jun. 2021 (BDT36 Mil) to Jun. 2022 (BDT33 Mil) and declined from Jun. 2022 (BDT33 Mil) to Jun. 2023 (BDT32 Mil).

ACME Laboratories Other Long Term Assets Historical Data

The historical data trend for ACME Laboratories's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Other Long Term Assets Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Long Term Assets
Get a 7-Day Free Trial 33.88 23.77 35.51 32.88 31.52

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.40 31.41 31.52 31.68 31.13

ACME Laboratories Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Other Long Term Assets
Comparable Companies
DHA:ORIONINFU DHA:AFCAGRO DHA:BEACONPHAR DHA:BXPHARMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
Website
https://www.acmeglobal.com
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines